16 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32724177 | Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease. | 2021 Apr | 1 |
2 | 24821093 | GM1 ganglioside enhances Ret signaling in striatum. | 2014 Aug | 1 |
3 | 7796105 | Enhanced restoration of striatal dopamine concentrations by combined GM1 ganglioside and neurotrophic factor treatments. | 1995 Mar 20 | 1 |
4 | 8164837 | Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism. | 1994 Apr | 2 |
5 | 1899692 | Preproenkephalin mRNA and methionine-enkephalin increase in mouse striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. | 1991 Mar | 1 |
6 | 2076347 | [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice]. | 1990 Nov | 2 |
7 | 2250172 | GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice. | 1990 Oct | 4 |
8 | 2532603 | Treatment with GM1 ganglioside reverses dopamine D-2 receptor supersensitivity induced by the neurotoxin MPTP. | 1989 Sep 13 | 1 |
9 | 2532697 | Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice. | 1989 | 2 |
10 | 2565752 | GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. | 1989 Apr 10 | 2 |
11 | 2568945 | GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism. | 1989 Aug | 8 |
12 | 2601883 | Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice. | 1989 Dec 4 | 3 |
13 | 2903475 | Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice. | 1988 Oct 5 | 2 |
14 | 3262149 | Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. | 1988 Oct | 3 |
15 | 3265839 | GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. | 1988 Apr | 1 |
16 | 3490632 | Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP. | 1986 Sep | 1 |